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Several studies have demonstrated that supplementation of rumen-protected 
choline (RPC) improves milk production in the lactating dairy cow; however, there are an 
equal number of studies failing to observe production responses.  To date, there are only 
three studies that provide quantitative information in ruminants on the metabolic fates of 
methyl groups derived from choline and Methionine (Met). This has limited the ability to 
predict when, and under what conditions, RPC supplementation will be beneficial.  The 
objectives of this thesis were to determine the interaction of choline and Met methyl 
group metabolism and the extent of methyl group transfer during lactation, and define 
what role, if any, is there for RPC in remethylation of homocysteine and in the sparing of 
Met in lactating animals. 
A preliminary study with lactating mice consuming a low protein basal diet (10%) 
was conducted.  From 11 to 15 d postpartum, stable isotopes of [methyl-2H3] choline and 
[methyl,2H3]Met replaced the unlabeled choline and Met in the basal diet to measure the 
metabolic fates of choline and Met including Met remethylation and sources of Met 
  
methyl in the mammary gland.  Isotopic analysis revealed that the liver is a major site of 
Met remethylation from dietary choline with a minimum choline methyl group 
contribution to Met remethylation of 35%. Mammary tissue was not a major site of Met 
remethylation from dietary choline (< 10% of Met methyl) as measure by Met methyl in 
mammary tissue and milk casein.  However, there was a significant unlabeled source of 
methyl groups contributing at a minimum of 45%  Met remethylation in the mammary 
tissue, presumably by de novo synthesis. This suggested that in addition to the liver, the 
mammary gland is an active site of methyl group transactions.  
In a subsequent study, lactating dairy cows were fed a total mixed ration 
formulated to meet the nutrient requirements with exception of metabolizable Met that 
was restricted to 1.49 % of metabolizable protein.  Treatments included a Control (basal 
diet) and RPC supplemented diet where the basal diet was top dressed with 15g/d RPC, 
diets were fed in a single reversal design with 2 week experimental periods.  Stable 
isotopes of Met, [1-13C] Met, [13CH3] Met, and [methyl-
2H3] choline were continuously 
infused on d 14 of each period to determine the metabolic fate and methyl transactions of 
Met methyl as measured in blood and milk casein.   
Treatment had no effect on milk production or composition. However, plasma 
free Met from choline transmethylation was shown to act as a significant contributor to 
casein synthesis.  Fractional Met remethylation rates in the control ad RPC treatments 





Methionine Met methyl loss within the mammary tissue appears to be minimal.  
Based on casein Met enrichment, upwards of 40% of Met present in casein had 
undergone transmethylation with choline serving as the ultimate methyl donor.  
Furthermore, plasma versus casein Met methyl enrichment data suggested that a 
significant amount of de novo methyl group synthesis occurs in the dairy cow’s 
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Dairy Cattle Nutrition Overview   
Physiologically, lactation can be considered the most demanding phase of the 
mammalian life cycle (Bauman and Currie, 1980) where at peak lactation,  the cow’s 
total energy requirements can be as much as 4 to 5 times those required for maintenance 
(NRC, 2001).  Because of the high nutrient demands to support milk production in early 
lactation, it is quite common for the dairy cow to mobilize body stores in order to mee 
lactation demands (Bauman and Currie, 1980; Coppock et al., 1974).  During lactation, 
the amounts of tissue mobilized can be as much as 50-90 kg body fat and 10-15 kg body 
protein (Andrew et al., 1994; Komaragiri and Erdman, 1997,1998) accounting for 30 to 
50% of a cow’s total energy stores.  In turn, utilization of body stores is reflected in lower 
body condition scores which have been associated with adverse affects on the health and 
reproductive efficiency of the animal (DeVries et al., 1999).  
Rumen fermentation allows for the digestion of cellulosic plant materials, 
facilitating the utilization of low quality feeds and forages allowing ruminants to thrive 
on feedstuffs which many herbivores animals would starve on.  Rumen fermentation and 
its concomitant production of volatile fatty acids (VFA) that are absorbed and utilized as 
energy sources, confer ruminants the ability to derive energy from cellulos  and 
hemicelluloses, substrates that are virtually indigestible in herbivores that lack 
fermentation compartments in their digestive systems.   
Not all aspects of rumen fermentation are favorable to the host animal.   Rumen 
fermentation frequently destroys components of nutritionally dense feedstuffs such as 
starches, amino acids, vitamins and unsaturated fatty acids where there could actually be 
a nutritional advantage to direct absorption in the small intestine essentially “bypassing” 
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transformations from rumen fermentation. While beneficial in many regards, rumen 
fermentation may ultimately limit the high producing dairy cow’s ability to fully exploit 
many nutritionally dense feedstuffs.   It is during periods of peak nutritional demand, 
such as during early lactation where more effective utilization of high quality or nutrient 
dense feedstuffs might alleviate the demand placed on the cow’s body stores and 
ultimately improve milk production as well as overall health of the dairy cow.    
As a result, there is now great interest in methods and products which provide 
nutrient dense, nutrient limiting, and/or high cost nutrients in forms which bypass the 
rumen to the small intestine, the site of absorption, to improve utilization.  Examples of 
such products include fat supplements, amino acids and vitamins where rumen bypass is 
allows for more favorable absorption and utilization of nutrients.  This effectively allows 
for selective supplementation and feeding of targeted nutrients to ruminants while 
preventing their degradation in the rumen. 
Most commercially available rumen-protected nutritional products have been 
developed for use in lactating dairy cow.  Rumen-protected fat products using calcium 
soaps of fatty acids (Megalac®, Church and Dwight Inc, Piscataway New Jersey) have 
been sold as energy supplements for more than 25 years.  Rumen-protected forms ofthe 
amino acids Met and lysine have been commercially available for more than 20 years 
(Smartamine-M® and Smartamine-L®, Addiseo USA Inc., Alpharetta, GA).  More 
recently, rumen protected forms of choline and niacin (Reashure and Niashure, Balchem 
Corp, New Hampton, NY) have become commercially available. These are just a few 
examples high quality, nutrient dense, and potentially limiting nutrients and ingredients 
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where rumen bypass for delivery to the small intestine for absorption can be 
advantageous in the lactating dairy cow.   
Previous work (Sharma and Erdman, 1988 and 1989) has demonstrated that 
dietary choline could be a limiting nutrient for milk production in the dairy cow.  In 
addition to the use of Met as an amino acid for milk protein synthesis, Met also plays as 
central role in methyl group metabolism (Almquist and Grau, 1944; DuVigneaud et al., 
1945).  As choline is a methyl rich compound which is destroyed during rumen 
fermentation (Neill et al., 1978; Sharma and Erdman, 1988b), rumen-protected choline 
could potentially be used to spare the use of Met as a methyl donor for choline synthesi 
or contribute to the re-methylation of homocysteine to Met.  Both Met and choline are 
now available in rumen-protected forms allowing for direct feeding. This thesis d als 
with the study of the interaction of choline and Met via the methyl sparing effect o  
choline in the lactating dairy cow. 
  
Methyl Group Metabolism 
One of the principal functions of the amino acid Met is as building block for 
proteins.  However, in addition to Met’s function as an amino acid, its constituent methyl 
group serves as readily available source of labile methyl groups required in many   
methylation pathways including synthesis of phosphatidylcholine,  methylation of 
proteins, DNA, RNA and a variety of other molecules (norepinephrine, catechols and 
sterols). Methionine is the immediate precursor of S-adenosylmethionine (SAM), the 
ultimate methyl group donor that is essential in over 100 transmethylation reactions 
(Lobley et al., 1996).  The products of transmethylation reactions can be found in every 
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cell and have functions ranging from regulation of DNA activity to cell membrane 
integrity (Selhub, 1999).  
Because of the limited dietary supply of Met in most common ruminant 
feedstuffs, coupled with the extensive utilization of methyl groups throughout te body, 
Met is considered either the first or the second limiting amino acid in ruminant diets 
(Lobley et al., 1995; Pinotti et al., 2002).  Ultimately, an effective means of de novo 
methyl group synthesis is required in order to meet the competing metabolic demands for 
Met as an amino acid and also as a methyl group donor.  
 
De novo Methionine Synthesis 
De novo Met synthesis occurs through remethylation of homocysteine, the 
byproduct of SAM transmethylation reactions.  After donating its methyl group, SAM is 
converted to S-adenosylhomocysteine (SAHC) (Figure 1).   Homocysteine may then 
undergo either transsulfuration/oxidation to cysteine (Cys) or remethylation to reform 
SAM.  The process of transsulfuration/oxidation is irreversible, serving both as source of 
the sulfur amino acid cysteine a vital component of proteins and as a route to remove 








Figure 1.1 General overview of methyl group transfer and de novo methyl group 
synthesis pathways. 
 
      
Reduced dietary supply of Met has been shown to correlate with a decrease in 
Cys. Reduced dietary Cys will ultimately require an increase in homocysteine 
transsulfuration/oxidation, further reducing the supply available for remethylation to Met.  
In several species it has been shown that Cys supplementation of Met deficient diets 
reduces the rate of transsulfuration/oxidation of homocysteine (Raguso et al., 1997).  This 
is most likely attributed to a transsulfuration/oxidation sparing effect as cysteine cannot 





Re-Methylation of Homocysteine 
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 Numerous studies have identified the negative consequences of Met deficiency and 
in turn methyl group deficiency which increases the level of importance of remethylation 
of homocysteine to Met (Selhub, 1999).  Methyl group availability and therefore Met 
availability is required for normal metabolic function and the animal’s ability to maintain 
adequate SAM concentrations. Synthesis of SAM is ultimately dependent on dietary 
intake of Met and methyl group contributors, providing a means by which SAHC can be 
remethylated to SAM.  In humans, the SAHC to SAM remethylation cycle may occur 2 
to 4 times before homocysteine undergoes final transsulfuration/oxidation.  The extent of 
remethylation is dependent on Met intake suggesting that this process is regulated in part 
by methyl group availability (Benevenga, 2007). Remethylation of homocysteine may 
occur by two distinct pathways:  Remethylation of homocysteine by de novo methyl 
group synthesis through N5-methyl-tetrahydrofolate or remethylation homocysteine by 
betaine derived from dietary choline.  
 Under normal circumstances, the tri-methylated compound choline through its 
oxidation product betaine, serves as the primary methyl group donor for re-methylation 
of homocysteine (Benevenga, 2007).  However, to date only three studies in ruminants 
(Emmanuel & Kennelly, 1984; Lobley et al., 1996; Preynat et al, 2009) provide any 





Re-Methylation of Homocysteine by N5-Methyltetrahydrofolate  
 8
De novo synthesis of methyl group was first discovered by Du Vigneaud et al., 
(1945). The remethylation of homocysteine to Met can occur in all tissues with N5- 
Methyltetrahydrofolate (MTHF) serving as the methyl donor (Selhub, 1999).  The final 
methyl transfer step to SAHC is Vitamin B12 dependent (Selhub, 1999).  Therefore, this 
metabolic pathway is both folate and Vitamin B12 dependent and a deficiency of either 
vitamin can result in perturbation of SAM-SAHC methyl transferase system.  Not 
surprisingly, the activity of this pathway increases during times of decreased methyl 
group intake (Pinotti et al., 2002).  As rumen fermentation destroys feed choline, (Neill et 
al., 1978, 1979) it is generally accepted that this pathway is more active in adult 
ruminants than in monogastric animals (Pinotti et al., 2002).  
 
Re-Methylation of Homocysteine by Betaine Derived from Choline 
Betaine, the product of choline oxidation via choline oxidase in tissues, is the 
primary source of methyl groups for remethylation of homocysteine to Met in humans 
(Bennevenga, 2007).  The remethylation of homocysteine by the betaine –choline 
pathway is dependent on the activities of two enzymes: choline oxidase and betaine-
homocysteine methyltransferase. In monogastric animals, most homocysteine re-
methylation occurs in the liver with limited amounts in other tissues such as the pancreas 
and kidneys (Selhub, 1999; Xue and Snoswell, 1986).  
Xue and Snoswell (1986) compared the activity of these enzymes in adult rat and 
adult sheep livers.  They found that choline oxidase and betaine-homocysteine 
methyltransferase activities were markedly lower in the adult sheep. Conversely, N5-
methyl-H4folate-homocysteine methyl transferase activity was greate  in sheep than rats 
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(Xue and Snoswell, 1986).  They concluded that the low activity levels of choline oxidase 
and betaine-homocysteine methyltransferase was a response to rumen degradation of 
dietary choline, ultimately minimizing the amount of choline absorbed from the diet.  
Given the limited availability of choline from the diet, it is plausible that choline would 
be conserved and spared from catabolism as a methyl donor, thereby reducing the need 
for more costly de novo methyl group synthesis.  Increased activity of the N5-methyl-H4-
folate-homocysteine methyl transferase would spare the use of choline as a methyl donor 
and perhaps is the main route by which remethylation of homocysteine to Met can occur 
in the ruminant animal.    
Xue and Snoswell (1986) suggested that increased activity levels of choline 
oxidase and betaine-homocysteine methyltransferase in both neonate and preruminant 
lambs were result of higher rates of dietary choline absorption in animals where an active 
rumen is not present.  Indeed, choline deficiency has been demonstrated in the dairy calf 
prior to weaning and choline supplementation corrects the deficiency (Johnson et al., 
1951)  Likewise in pre-ruminant sheep, adequate dietary supplies of choline up-regulate 
choline oxidase and betaine-homocysteine methyltransferase  activities (Xue and 
Snoswell, 1986).  It has been shown that increased choline availability results in 
increased enzymatic activity associated with the choline-betaine remethylation pathway 
in monogastrics (Selhub, 1999). This same choline dependent upregulation and use of 
choline methyl groups for homocysteine remethylation functions in pre-ruminants (Xue 
and Snoswell, 1986) just as it does in on monogastrics species where it is considered to 
be the major source of methyl groups. (Bennevenga, 2007; Selhub, 1999).   
Transsulferation and Oxidation of Homocysteine 
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 The transsulfuration and oxidation of homocysteine (Figure 1) provides the means 
by which Cys is synthesized from Met. This also provides a pathway by which excess 
Met and homocysteine are removed, both of which are toxic at high concentrations 
(Selhab, 1999).  In the event that methyl group donors are limited, protein sources may be 
mobilized for SAM, which in turn increases the production of homocysteine.    
Homocysteine must be remethylated to Met or removed from the body via the 
transsulfuration/oxidation pathway (Selhub, 1999).    The process by which homocysteine 
is either remethylated and or undergoes transsulfuration or oxidation,  is remarkably well 
regulated by several complex feedback loops that  respond  to dietary intake of Met, the 
availability of  methyl group donors and the animals basal need for methyl groups 
(Selhub, 1999).   As Met availability decreases, there is a greater demand for re-
methylation of homocysteine which is met in large part through the increased activity of 
the 5-MTHF pathway (Selhub, 1999). Synthesis of 5-MTHF is dependent on the 
availability of 5-MTHF reductase enzyme which  is inhibited when SAM concentrations 
are high.  However, as SAM concentrations decline the rate of 5-MTHF reductase 
synthesis increases and subsequently improves the rate of re-methylation (Selhub, 1999).   
Intercellular concentrations of SAM are regulated in part by the rate of synthesis 
from intercellular Met.   According to Selhub (1999), the activity of two enzymes 
required for SAM synthesis, one having a high affinity for Met and the other a low
affinity for Met, fluctuate with the intercellular concentration of Met. As Met 
concentration declines activity of the high affinity enzyme decline as well, reducing SAM 
synthesis, conserving Met and subsequently increasing the rate of 5-MTHF reductas  
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synthesis, the opposite effect is noted when Met is considered to be at or above normal 
concentrations (Selhub, 1999).   
 
Effect of Choline and Methionine Deficiency  
Methionine and choline deficiency has been shown to induce fatty liver, reduce 
feed efficiency, restrict growth, result in weight loss and attenuate insulin resistance and 
glucose intolerance (Riziki et al., 2006; Raubenheimer et al., 2006).  A classic symptom 
of choline deficiency is fatty liver first reported by Hershey and Soskin (1931) in dogs. It 
has been proposed that a general deficiency of methyl groups leads to fatty liver as a 
result of inadequate amounts of the phospholipid phosphatidylcholine (PC) (Pinotti et al., 
2002).    Phosphatidylcholine is an integral component of lipoproteins that are required 
for export of triglycerides in the form of very low density lipoproteins (VLDL) from the 
liver. The attenuation of insulin resistance and glucose intolerance could be the result of 
an inability to oxidize free fatty acids in liver, resulting in fatty liver. Systemic weight 
loss seen in methyl group deficient diets may be a result of protein catabolism f r methyl 
group supply and an inability to oxidize dietary fatty acids effectively for ene gy.  These 
symptoms suggest that severely reduced methyl group availability has profound 
implications on normal metabolic function.      
 
Choline Synthesis  
Because of almost complete rumen degradation of dietary choline, choline must 
be synthesized e novo in the ruminant in order to meet biological demands (Dawson et 
al., 1981, Robinson et al., 1984; Pinotti et al., 2002).    In ruminants, significant choline 
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synthesis occurs in the extra-hepatic tissues and to a more limited degree in the liver 
(Robinson et al., 1984).   This contrasts with many monogastric species including 
humans, rats and swine that obtain a large fraction of their choline requirements from he 
diet, and therefore may have limited need for de novo choline synthesis (Robinson et al., 
1984).  It has been shown that pre-ruminants also receive the majority of their choline 
requirement via dietary sources similarly resulting in limited needs for de novo synthesis 
(Xue and Snoswell, 1986).  
De novo choline synthesis in mammals is via one distinct pathway catalyzed by 
phosphatidylethanolamine N-methyltransferase (PEMT).   Phosphatidylethanolamine N-
methyltransferase, glycine N-methyltransferase (GNMT) and guanidinoacetate 
methyltransferase (GAMT)   all play a major role in the regulation of methyl group 
metabolism and in the synthesis and remethlylation of homocysteine (Williams and 
Schalinske, 2007).  Specifically, phosphatidylethanolamine N-methyltransferse acts as a 
catalyst for the pathway that allows for the repeated methylation of 
phosphatidylethanolamine to phosphatidylmonomethylethanolamine, phosphatidyl 
dimethylethanolamine and finally phosphatidylcholine (Williams and Schalinske, 2007).   
Three methyl groups derived from SAM and ultimately Met are required for the synthesis 
of one molecule of choline. Ultimately this pathway consumes a far greater perc ntage of 
methyl groups then the GAMT and GNMT pathways and thus may play a larger role in
the regulation of homocysteine remethylation. The byproduct of this reaction is hree 
molecules of homocysteine that must either be degraded via transsulfuration/oxidation or 
remethylated to Met (Stead et al., 2006).      
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The sources of SAM for PEMT choline synthesis reaction may vary depending on 
the current nutritional status of the animal and availability of Met, folate, vitamin B12 
(Pinotti et al., 2002).  Because methyl group synthesis is metabolically costly, during 
Met, folate, or vitamin B12 deficiency it can be presumed that choline synthesis is limited, 
and therefore choline would be considered an essential nutrient (Pinotti et al., 2002).   
Deficiencies of Met, folate or vitamin B12 are confounded by the lack of choline 
absorption from the diet in ruminant animals.  Therefore, the ability to supplement the 
diet with RPC is a possible means to spare Met from catabolism for choline synthesis and 
reduce the potential for methyl group deficiency.  
 
De novo Methyl Group Synthesis 
Du Vigneaud et al. (1945) was first to report de novo methyl group synthesis 
discovered by incorporation of 2H from deuterium in choline. They initially theorized that 
the rat was capable of synthesizing methyl groups de novo, most likely via gut micro 
flora. Shortly thereafter, Sakami et al., (1950) demonstrated with C14-formate that the rat 
was able to synthesize Met and choline methyl groups from formate in vivo and in vitro 
using liver tissue, confirming de novo synthesis of methyl groups in the mammal.   
De novo methyl synthesis can occur from the demethlyation of dimethylglycine to 
formate.   Formate is subsequently reduced to N5- Methyltetrahydrofolate (MTHF) which 
serves as a methyl donor for remethylation of SAHC to SAM. S-adenosylmethionine can 
be used in the SAM methyltransferase pathways for formation of methylated products 
including choline. The synthesis of Met via this route is dependent on the presence of 
folic acid and vitamin B12.  
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Methyl Transfer Reactions 
 Methyl transfer reactions are essentially limited to two specific pro esses, one that 
allows for methyl groups to be transferred from S-adenosylmethionine to an array of 
methylated compounds and the second being the transfer of methyl groups from choline 
to homocysteine via betaine for the synthesis of SAM.  Methyl groups from SAM are 
utilized for synthesis of methylated compounds such as creatine, norepinephrine and 
VLDL-lipoproteins in addition to choline via a pathway requiring sequential donation of 
methyl groups to form the choline precursor phosphatidylcholine.     
 Emmanuel and Kennelly (1984) estimated that as much as 28% of Met may be 
supporting choline synthesis via the SAM transmethylation pathway with 6% of choline 
in their studies being derived from dietary Met in lactating goats.  However, there was no 
indication of choline supporting Met synthesis in this study based on measurements of 
Met enrichment following labeled choline infusion (Emmanuel and Kennelly, 1984).   A 
later study by Lobley et al. (1996) evaluated the impact of choline and creatine infusion 
on Met recycling in sheep.   Infusion of choline and creatine significantly decreased both 
Met recycling and irreversible loss rate indicating that choline spared Met from 
catabolism (Lobley et al., 1996).   
 
Methionine-Choline Interaction in Poultry 
Klose and Almquist (1941) found that Met deficient diets supplemented with .5% 
choline and .9%, homocysteine resulted in growth rates comparable to chicks fed a 1% 
Met supplemented diet.  When choline supplementation was limited to .2% of the diet, 
growth was reduced dramatically, leading the conclusion that homocysteine util zation in 
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the Met deficient diet was dependent largely on an adequate supply of dietary choline
(Klose and Almquist, 1941)   This observation was confirmed by Grau and Almquist 
(1943) as chicks that were depleted of choline over a period of 16 to 21 days and then 
subsequently supplemented with homocysteine showed no improvement in growth in 
contrast to Met supplemented diets that significantly improved growth.    Almquist and 
Grau (1944) went on to demonstrate that the dietary choline requirement in chicks ould 
be partially met through supplementation with Met and betaine.  They concluded that 
betaine could completely replace the dietary choline.  However, choline showed a sparing 
effect on Met and betaine requirements (Almquist and Grau, 1944).  
Miles et al. (1983), found that the Met sparing effects of choline were correlated 
positively with sulfate availability in broiler diets.  Miles et al., (1987) showed that 0.11% 
choline or an equal molar rate of betaine would elicit an increased growth respons  in 
chicks fed basal diets marginally limited in Met, choline, and betaine.  Growth response 
was further improved with the addition of 0.24% Met in diets containing supplemented 
choline and or betaine (Miles et al., 1987).  However, in laying hens fed of a corn-
soybean meal basal diet that was marginally limiting in choline and Met, there was no 
improvement in production traits with the addition of 0.044% choline while an equal 
molar addition of Met (0.033%) significantly improved egg production (Miles et al., 
1987). They theorized that choline supplementation was capable of eliciting a positive 
production response only when other sulfur amino acids are at or above the absolute 
minimal required level. Conversely, the benefits of choline supplementation were lost 
when choline is not the limiting factor in the diet.  
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Lowry et al. (1987) determined that the minimal concentration of dietary choline 
for chicks to achieve maximal growth rate was 625 mg/kg.  Dietary supplementation of 
betaine at 1000 mg/kg in a purified choline-free diet only decreased the choline dietary 
requirement in chicks to 467 mg/kg (Lowry et al., 1987).  Based on these results, Lowry 
et al. (1987) theorized that betaine was not capable of meeting more than 25% of choline 
requirements of the chick.  Additionally, Lowry et al. (1987) determined that growth 
responses to betaine supplementation were found only in diets with adequate dietary 
choline, this suggested that minimal choline requirements needed to be met first in order 
to induce positive growth responses to betaine.    
More recent work by Dilger et al. (2007) showed that a minimum dietary 
concentration of 150mg/kg of preformed choline was required per day when betaine was 
included at 1000mg/kg diet.  Furthermore, they suggested that up to 50% of the choline 
requirements in the growing chick could be satisfied via betaine.    
 
Methionine-Choline Interaction in Swine 
Bell et al. (1950) was one of the first to establish that Met was an essential amino 
acid in swine with a requirement of 0.07% to 0.27% of the growing pig diet when dietary 
protein concentrations were held at 10%. With Met supplementation in soybean meal 
based diets, they were able to demonstrate growth efficiency and biological values 
comparable to that of whole egg protein, the “Gold Standard” for protein at that time.  
Dyer et al., (1949) had previously demonstrated that choline chloride supplementation in 
a low protein diet could spare Met in weanling swine.  They found that when 250 mg of 
choline chloride or 0.2% dl-Met were added to  basal diets containing 20% crude protein; 
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growth rates were significantly improved.  However, there was no significa t difference 
between the choline supplemented diet, the Met diet and a diet supplemented with both 
choline and Met, suggesting that these effects were not additive. (Dyer et al., 1949).  
Alternatively, the amounts added individually were sufficient to meet the animal eeds.  
Based on the results of this study Dyer et al., (1949) concluded that choline was able to 
effectively spare Met.   
Dyer and Krider (1950) found that the Met sparing effect of choline was negated 
when vitamin B12 was supplemented.  Choline supplementation to a basal diet that 
included vitamin B12 did not improve weight gain or feed efficiency (Dyer and Krider 
1950).  Based on these results, Dyer and Krider (1950) theorized that vitamin B12 could 
effectively spare choline. 
More recently, Lovett et al. (1986), investigated the roles of sulfate in sparing 
dietary sulfur containing amino acids and specifically Met and choline.  A sulfate 
supplemented diet with either  added choline or Met improved average daily gain over 
the basal diet while adding both Met and choline did not further improve ADG or feed 
conversion ratios.  According to the authors, the basal diet was not deficient in either Me  
or choline, both of which were included at lower levels than that of Cys.   However, when 
Met and choline were supplemented in the diet, Cys became more limiting.   Lovett et al. 
(1986) suggested that the inclusion of sulfate in the Met and Cho supplemented diets 
resulted in a higher growth by sparing dietary Cys.    
Earlier studies in swine by Curtin et al., (1952) and Shelton et al., (1951) 
supported the hypothesis that dietary Cys supplementation in low protein diets can spare 
Met.  Curtin et al., (1952) showed that supplemental Met requirements were significantly 
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lower when Cys was included in the diet in adequate amounts. Shelton et al., (1951) 
demonstrated that L-Cys could replace up to one half of the total dietary Met 
requirements in growing pigs.  This sparing effect appears to be a direct result of the 
decreased demand for the transsulfuration and oxidation of homocysteine for Cys 
synthesis.   
 
Rumen Degradation of Choline 
 Phosphatidylcholine, an immediate precursor to choline is found in relative 
abundance in many plants and feedstuffs and could be considered to be the primary form 
of choline in the ruminant diet (Neill et al., 1978). However, dietary sources of choline 
have been shown to have limited to no bioavailability in ruminants (Neill et al., 1978; 
Pinotti et al., 2002, Sharma and Erdman, 1988b).  Sharma and Erdman (1989b) found 
nearly complete rumen degradation of choline incommonly fed feedstuffs of in situ
rumen incubations.  Dietary choline chloride was completely degraded using in stu 
incubations (Sharma and Erdman 1989b) and in dairy cows fed high amounts (> 300g) of 
choline chloride (Sharma and Erdman 1988b). Neill et al. (1978) found that the vast 
majority of feed choline in hydrolyzed and rapidly degraded to acetaldehyde and 
trimethlyamine.  Trimethylamine was rapidly converted to methane gas in the rumen and 
more than 75% of choline methyl is converted into methane within 6 h in the rumen.  
(Neill et al., 1979)  
 It has been suggested by Broad and Dawson (1976) that a limited amount of 
dietary choline may be incorporated into rumen ciliate protozoa.  However, studies by 
Neill et al. (1979) showed very minimal amounts of choline incorporated as PC in ciliate 
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protozoa and that protozoa do not appear to be even a minor contributor to absorbed 
choline or methyl groups in ruminant animals. Neill et al., (1979) calculated that sheep 
absorb less than one fiftieth the amount of dietary choline required by non-ruminants, 
estimating that in total they absorb no more that 20-25 mg choline per day from the diet.  
Further, defaunated sheep failed to show symptoms of choline deficiency, supporting the 
conclusion that protozoa do not provide significant sources of choline for intestinal 
absorption (Dawson et al., 1981).  In conclusion, dietary choline whether in the common 
plant form of PC or as choline chloride is completely destroyed by rumen fermentation.  
This suggests that ruminants must de novo synthesize the majority of their choline  
needed to meet their metabolic requirements. 
 
Effects of Choline on Milk Production  
 As dietary choline is completely degraded in the rumen, experiments measuring 
milk production responses of lactating dairy have used two approaches to deliver choline
directly to the small intestine: 1) postruminal choline infusion; and 2) feeding rumen-
protected forms of supplemental choline.   
 
Postruminal Choline Infusion Experiments 
Initial experiments by Sharma and Erdman (1988ab) used abomasal infusion of 
choline since rumen-protection technology was not available to feed choline directly at 
that time.  In these experiments 30 to 90 g/d choline was abomasally infused over 3-4 
week experimental periods.  Milk production responses to postruminal choline infusion 
ranged from 0 to 3.8 kg/day with small increase in milk fat percentage.  Generally there 
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was no effect of choline infusion on feed intake.  Based on these experiments they 
concluded that postruminal dietary requirement for choline was about 30-50 g/d.  While,
many experiments were positive, others showed no effect, suggesting that choline might 
be a limiting nutrient for milk production in the dairy cow.    
Subsequently, Sharma and Erdman (1988a) tested the potential for Met and 
choline interactions using a combination of choline or Met postruminal infusion with or 
without 2-amino-2methyl-1-propanol (2AMP) which is a competitive inhibitor of PEMT 
and theoretically would block PC synthesis using SAM.  Cows receiving post-ruminal 
choline had greater milk fat and milk protein production than those receiving the Met 
even though they were administered on a molar equivalent basis (Sharma and Erdman, 
1988a).   Subsequent post-ruminal infusion of 2AMP with Met, resulted in a further 
decrease in milk protein and fat-corrected milk yield compared to cows receiving 2AMP 
and choline infusion (Sharma and Erdman, 1988a).  These results suggested that Met was 
being used as a methyl donor for de novo choline synthesis and that choline and Met 
interacted in a similar manner in dairy cows as had previously been observed in 
monogastric animals.   
 
Rumen-Protected Choline Supplementation Studies  
Numerous studies have been conducted in order to determine the efficacy of 
rumen protected choline supplementation on milk production and composition (Table 
1.1).  Several studies have noted an increase or a tendency for higher milk yield within 
RPC treatment groups (Erdman and Sharma, 1991; Erdman, 1994; Hartwell et al., 2000; 
Pinotti et al., 2003; and Davidson et al., 2008). However a similar number of studies 
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failed to note a positive response to RPC supplementation (DiConstanzo and Spain, 1995; 
Hartwell et al., 2000; Janovick-Guretzky et al., 2006; Davidson et al., 2008; Piepenbrink 
and Overton, 2000). Fat yield was increased within some RPC treatments (Erdman and 
Sharma, 1991; Erdman, 1994; Hartwell et al., 2000; Piepenbrink and Overton, 2000; 
Pinotti et al., 2003; Davidson et al., 2008) while others showed no significant effect of 
RPC supplementation.  (DiConstanzo and Spain, 1995; Piepenbrink and Overton, 2000; 
Janovick-Guretzky et al., 2006; Davidson et al., 2008; Hartwell et al., 2000).   Protein 
yield in response to RPC supplementation increased within two studies (Erdman and 
Sharma, 1991; Erdman, 1994) and decreased in one study (Hartwell et al., 2000) which 




Table 1.1 Summary of dairy cow rumen-protected choline (RPC) supplementation 
studies with or without rumen-protected methionine (RPM) or rumen-protected betaine 
(RPB). 
 
1Relative to control .2Calculated from milk fat percent and milk yield (kg/d). 3Calculated from milk protein percent and milk yield 
(kg/d).  
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The variation in these results may be explained in part through differences in study 
design. There are few consistencies between diets, supplement quantity, length of 
treatments and stage of lactation.  Basal diets, when comparing across experim nts vary 
from Met limiting to adequate based on NRC recommendations.   Several studies 
(Erdman and Sharma, 1991; Janovick-Guretzky et al., 2006; Hartwell et al. 2000) have 
attempted to elucidate the relationship between choline and various sources and levels of 
dietary protein.   Erdman and Sharma (1991) were able to demonstrate a tendency for 
increased milk yield with RPC supplementation with the magnitude of this increase being 
greater in animals receiving a lower protein diet (13.0 vs. 16.5%).   However, Janovick-
Guretzky et al. (2006) did not observe a positive production response from RPC 
supplementation when feeding a diet that was in limiting in metabolizable protein fl w to 
the small intestine but otherwise adequate based on NRC recommendations.  Janovick-
Guretzky et al. (2006) suggested that the amount of RPC (15g/d), half of what was used 
by Erdman and Sharma (1991), may not have been sufficient for a production response.    
An earlier study by Hartwell et al. (2000), noted a positive production response 
when feeding as little as 12g/d RPC with a low RUP (4.0%).  Hartwell et al. (2000), was 
designed in part to evaluate the effect of RUP in addition to RPC.  A significant decli e 
in DMI post parturition was seen when increased RUP (6.2%) were fed prepartum.  
Animals consuming a treatment diet with a lower RUP (4.0%) prepartum did not exhibit 
a decline in DMI and had an increase milk yield with RPC supplementation, this 
suggested indicating that protein level in the prepartum diet may contribute to RPC 
efficacy (Hartwell  et al., 2000).   Cumulatively, these studies suggest that the amounts 
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and type of protein, as well as when it is fed may be a significant factor in affecting the 
dairy cows response to RPC supplementation.   
In addition to variation in basal diets and the quantity of choline supplementation 
(6 to 75 g/d) in the reported studies, there are significant differences in production status 
of cows used across these experiments.   Studies in early to mid lactation multiparo s 
cows receiving RPC had both positive production responses (Erdman and Sharma, 1991; 
Erdman, 1994; Piepenbrink and Overton, 2003; Pinotti et al., 2003; Davidson et al., 
2008) as well as no effect of treatment (DiConstanzo and Spain, 1995; Piepenbrink and 
Overton, 2000; Janovick-Guretzky et al., 2006).     
The time at which RPC was first administered (as early as three weeks pre partum 
to several months post partum),  in addition to the length of time supplementation was 
applied (42-150 days), makes comparison between these studies difficult and further 
confounds the understanding of when, and under which conditions, RPC supplementation 
will be beneficial.   Furthermore these studies are limited largely to multiparous cows 
with the exception of Erdman and Sharma (1991) and Davidson et al. (2008).  Erdman 
and Sharma (1991) utilized both multiparous and primiparous cows but data was not 
separated by parity.   
Davidson et al. (2008), reported the effects of RPC supplementation in both 
multiparous and primiparous cows.  In multiparous Holstein cows, a significant increase 
in milk yield and milk protein was noted with RPC (40g/d) supplementation where cows 
also responded to the addition of rumen protected methionine (20g/d) (Davidson et al., 
2008).  Rumen-protected betaine (45g/d) had no effect on production data, suggesting 
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that choline may be sparing methionine via phosphatidylcholine rather than contributing 
to the remethylation of homocysteine (Davidson  et al., 2008).   However, in primiparous 
Holstein cows in the same study there was no effect of supplementation with RPM, RPC 
or RPB, suggesting that RPC responsiveness might be limited to diets which elicit a 
response to RPM.  
 
Dietary Choline in Transition Cows 
Transition cow production performance and physiological response to rumen 
protected choline supplementation has been evaluated in several studies.  RPC 
supplementation did not affect dry matter intake pre or post partum in studies by 
Hartwell, et al., 2000, Pinotti et al., 2003, Piepenbrink and Overton, 2003, Janovick-
Guretzky et al. 2006 or Cooke et al., 2007. However, in two studies (Oelrichs ET al.2004; 
Chung et al., 2005) a significant decrease in DMI was associated with RPC 
supplementation.  
There was no effect of RPC supplementation on liver triacylglycerol (TAG) 
concentrations during early lactation in studies by Hartwell, et al., (2000) and 
Piepenbrink and Overton, (2003).  In contrast, Cooke et al. (2007), observed a decrease in 
liver TAG concentrations during fatty liver induction when RPC was supplemented. 
Additionally, TAG clearance from the liver was increased with RPC supplementation 
following fatty liver induction (Cooke et al., 2007).   
 Piepenbrink and Overton, (2003), noted an increase in liver glycogen 
concentrations with RPC supplementation but no effect on blood ß –hydroxybutyrate 
(BHBA).   Cooke et al., (2007) found no effect of RPC on plasma glucose or (BHBA) 
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during fatty liver induction.  Janovick-Guretzky et al., (2006) noted a decline in plasma 
BHBA with RPC supplementation in Jersey but not Holstein cows while Pinotti et al. 
(2004) noted tendency for increased plasma glucose in response to RPC supplementation.  
The effect of RPC on milk production responses in early lactation cows is far 
from consistent. Several studies  have noted increases in milk yield, fat, or protein 
content (Erdman, 1994; Pinotti  et al., 2000; Piepenbrink and Overton, 2003; Pinotti  et 
al., 2004) while others have noted a decline (Hartwell et al., 2000) or no effect of RPC 
supplementation (Janovick-Guretzky et al., 2006).  
Body condition score and weight gain/loss  in response to RPC supplementation 
varied as well with some noting no effect of treatment  (Piepenbrink and Overton, 2003; 
Janovick-Guretzky et al., 2006), others noting lower BCS and or increased weight loss 
with RPC supplementation (Hartwell et al. 2000).  
Plasma nonesterified fatty acid (NEFA) concentration is frequently used as an 
indicator of fatty liver disease (Grummer, 1995).  Studies by  Hartwell et al. (2000, 
2001), Piepenbrink and Overton (2002) and Janovick-Guretzky et al. (2006),  reported no 
effect of RPC supplementation on plasma NEFA while Pinotti et al. (2003, 2004) and 
Cooke  et al. (2007)  showed decreases in plasma NEFA when RPC was supplemented.    
 
Fundamental Questions Regarding Rumen Protected Choline Supplementation 
When viewed cumulatively the results of these studies suggest a possible need for 
choline supplementation, however two fundamental questions remain unanswered; 
1) What are the dietary and physiological conditions under which choline 
supplementation will be beneficial to lactating cows? 
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2) What are the amounts of rumen protected choline that are required in dairy cow diets 
to affect milk production and milk composition? 
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enrichment; ES, treatment sample enrichment; dH2O, deionized water; DTT, 
dithioerythritol; MET, methioine; SSA, sulphosalicyclic acid; tBDMS, tertiary-
butyldimethylsilyl.  
Abstract  
The objective of this study was to determine the extent of methyl group transfer from 
CHOL and MET during lactation in C57BL/6 mice.  Mice were pair fed a purified low 
protein (10%) diet supplemented with choline chloride or methionine on a methyl group 
equivalent basis from d 1 to d 15 of lactation.  From d 11 to 15 stable isotopes of [methyl-
2H3] choline and [methyl,
2H3]Met replaced the unlabeled fraction.  Growth data 
suggested that pups in both treatment groups were methyl group deficient by d 10 of the 
treatment period.  Samples collected on d 15 indicated that free liver methionine methyl 
enrichment from choline was of 35% of that from MET supplementation, establishing a 
minimum choline contribution to remethylation in the liver.  The liver was the major site 
of methionine remethylation from dietary choline in the mouse.  Conversely, mammary 
tissue did not appear to be a major site of methionine remethylation from choline.  The 
data suggested that there was an unlabeled source of methyl groups that contributes to 
remethylation in the mammary tissue at a rate far in excess of that from choline.  There 
were no treatment effects on liver tissue:liver free and mammary tissue:ca ein enrichment 
ratios suggesting that both treatments resulted in similar fractional rates of methionine 
remethylation.  The data suggested that de novo methyl group synthesis was induced for 
MET remethylation in the mammary gland resulted in significant MET synthesis. 
 
Introduction  
In addition to methionine’s function as an amino acid, its constituent methyl 
group serves as readily available source of labile methyl groups required in numerous  
methylation pathways including synthesis of phosphatidylcholine,  methylation of 
proteins, DNA, RNA and a variety of other molecules (norepinephrine, catechols and 
sterols). Methionine is the immediate precursor of S-adenosylmethionine (SAM), the 
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ultimate methyl group donor in over 100 transmethylation reactions (1).  Methyl groups, 
made available via the transmethylation pathway, can be found in every cell and have 
functions ranging from regulation of DNA activity to cell membrane integriy (2).  
Numerous studies have identified the negative consequences of Met deficiency and in 
turn methyl group deficiency which increases the level of importance of remethylation of 
homocysteine to Met (2).  It has been observed that Met deficient diets result in reduced 
rate of transsulfuration/oxidation of homocysteine and increased remethylation of 
homocysteine to Met (3).  
 Betaine, the product of choline oxidation, is the primary source of methyl groups 
for remethylation of homocysteine to methionine in humans, mice and rats (4,5,6).    The 
remethylation of homocysteine by the betaine –choline pathway is dependent on the 
activites of two enzymes: choline oxidase and betaine-homocysteine methyltransferase.  
The activity of these enzymes in humans appears to be regulated in part by plasma 
methionine and homocysteine concentrations (7).  In monogastric animals, most 
homocysteine remethylation occurs in the liver with limited amounts in other tissues such 
as the pancreas and kidneys (2,4).    
To date, there is no quantitative data on the interrelationship of CHOL and MET 
methyl group metabolism within specific tissues of the lactating mouse.   Th refore, an 
experiment with lactating mice was conducted with the objective of determining the 
extent and tissue specificity of methyl group transfer from dietary MET and CHOL 





Materials and Methods 
Mice and Treatments.  The experiment was reviewed and approved by the University of 
Maryland Institutional Animal Care and Use Committee under Protocol R-05-57.  Ten 
pregnant C57BL/6 mice were obtained from the University of Maryland Animal and 
Avian Sciences animal colony.  Mice were individually housed in plastic shoebox 
containers under climate controlled conditions at 23°C with 12h:12h light dark cycle.  
Bedding was changed weekly and water bottles changed every other d with feed and 
water available continuously. Mice were fed a standard lab animal diet (Lab Diet 5001 
Rodent Diet, PMI Nutrition International, LLC, Brentwood, MO) ad libitum throughout 
pregnancy until parturition.   
On d 1 postpartum, the dams were switched to a pelleted low protein (10%), methyl 
group deficient basal diet that was otherwise nutritionally complete (8).  Dam-litter pairs 
were blocked on litter size and d of lactation and randomly assigned within block to one 
of two experimental diets (Table 2.1).  Dietary treatments consisted of equal molar 
methyl group additions of either D,L- Methionine (300 mg/100g) or Choline (9.5 
mg/100g Choline-Cl).  
The diets were prepared as follows:  Dry ingredients were thoroughly mixed 
for several min with a small hand mixer, during which time a modest amount of 
water was added. The final mixed product resembling pliable dough was divided 
into spoonfuls and air dried to a constant weight prior to feeding.  During d 1 to10, 
diets containing unlabeled Met and choline were fed.  From d 11 to 15, unlabeled 
choline was replaced with [methyl-2H9] choline (98 atoms percent, Cambridge 
Isotope Laboratories, Andover, MA) while unlabeled Met was replaced with 
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[methyl-2H3]Met (methyl-
2H3, 98 atoms percent, Cambridge Isotope Laboratories, 
Andover, MA).   
Mice were monitored twice daily for overall health and onset of parturition. 
Parturition day was based on the presence of pups at the morning health check at which 
time, they began on their experimental diets. Feed intake and refusals were record d daily 
throughout the study.  Dams were weighed every 2 d beginning at on d 2 post partum, 
and litters every 2 d beginning at d 6.  
 
Sample Collection.  Milk samples were collected from dams on d 11, 13, and 15 
postpartum using procedures similar to those previously described (9).     Briefly, dams 
were isolated from the pups in a separate plastic shoe box container for a period of 2 h 
prior to milk collection.  Dams had ad libitum access to feed and water during this period.   
At the end of the isolation period and prior to milk collection, mice were gently restrained 
by hand and given an inter-abdominal injection of 0.3mL containing 1IU/mL oxytocin in 
sterile saline.  Mice were then returned to their respective containers for 5 min after 
which they were again gently restrained by hand and their teats were manually 
stimulated.  Milk was collected in a silanized Pasteur pipette under vacuum from a water 
aspirator as using used as a source of vacuum (10).  Milk was then transferred from the 
Pasteur pipette into hematocrit tubes via capillary action and sealed with critaseal.  
Hematocrit tubes were placed into individual plastic test tubes and labeled to identify 
mouse and date of collection. Following collection, samples were centrifuged for 20 min 
at maximum speed on a clinical hematocrit centrifuge (International Micro-Capillary 
Centrifuge Model MB, International Equipment Company, Needham Hts., MA)  (10). Fat 
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percentage was measured using a hematocrit/creamatocrit and then stored at -20°C until 
further analysis (10).  
Following the d 15 milk collection, dams and pups were euthanized by isoflorane 
asphyxiation and placed ventral side down on a marble slab that had been preciously 
washed with .9% saline and set on a bed of ice to rapidly reduce specimen temperature.  
Following a midline incision passing through the skin and peritoneum, livers and kidneys 
were removed and the kidneys were dissected of visible fat. Livers and kidneys were 
washed in ice cold .9% saline, placed in tin foil and then frozen at -20°C for later 
analysis. Immediately after liver removal, blood samples were from dams were collected 
via the hepatic portal vein in a 1 mL heparinized syringe fitted with a 21 gauge needle.  
Samples were gently mixed within the syringe and then separated into 100 µL aliquots 
and frozen immediately at -20°C.   
Stomachs from the pups were removed and the milk within was expelled by 
gently pressing the stomach content into a 2 mL Eppendorf tube.  The contents of all 
littermate pup stomachs were stored collectively at -20°C for later analysis.  Samples of 
muscle from the hind limbs and mammary tissue of the dams were collected and stored at 
-20°C.  The small intestine was removed from the stomach up to but not including the 
ceca. The small intestine was flushed with 20 mL of ice cold 0.9% saline in order t 
remove all digesta, the tissue was stored in the same manner as the previous sample .  All 
tissue samples were lyophilized for 48 h or until reaching complete dryness, prior to 
chemical analysis.  
Sample Preparation and Analytical Procedures.  Milk fat was separated from the 
protein and water fraction by scoring the glass hematocrit tube and gentlybreaking the 
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tube at the junction of the fat and non-fat fraction.    The non-fat fraction was placed in a 
1.5mL micro-centrifuge tube, centrifuged at 250 × g for 1 min or until entirely expelled.  
One mL deionized H2O (dH2O) was added, the sample vortexed, and 1M HCl added to 
adjust the pH to < 4.  Samples were vortexed vigorously and then centrifuged at 12000 × 
g  for 10 min to precipitate the casein pellet.  The supernatant was removed, and 1 mL 
dH2O was added along with 1 drop of 6M NaOH to neutralize the HCl.  Samples were re-
suspended followed by a second precipitation with 1M HCl and centrifugation.  The 
supernatant was removed, the casein pellet was washed twice with 0.5 mL of dH2O and 
the final pellet frozen and lyophilized as described above.    
Dried casein samples were hydrolyzed with 0.5 mL of 2N HCl containing 0.05% 
dithioerythritol (DTT) at 100°C for 24 hours. Cooled hydrolysates were transferred to 2.5 
mL micro-centrifuge tubes and centrifuged briefly, reaching a final speed of 10,000 rpm 
(Eppendorf MiniSpin® rotor 5452000018, Hamburg, Germany) to precipitate debris.  
The supernatant (0.25mL ) was applied by pipette to mini-columns with 1g cation 
exchange resin (AG 50W-X8, 100-200 mesh, H+ form, Bio-Rad, Hercules, CA)  
previously prepared by washing with 12 mL dH20.  Following sample application, 
columns were monitored for elution cessation at which point a wash of 8 mL dH20 was 
applied.  Waste elution containing acids, salts and neutral compounds was discarde .  
Amino acids bound to the resin were eluted with 4 mL of 2M NH4O  followed by 2 mL 
dH20.  The NH4
+ and dH20 elutions were collected in 8 mL glass pots and then covered 
with punctured caps.  The samples were frozen overnight at -20°C and then lyophilized 
until completely dry.   
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Dried samples were transferred to a 1 mL V-vials with 150 µL of dH20 and then 
dried completely under a stream of N2 gas at 40°C prior to preparing the tertiary-
butyldimethylsilyl (tBDMS) derivatives. To the dried sample, 50 µl of N-(t-
butyldimethylsilyl)-N-methyltrifluoroacetamide with 1% tert-butyldimethylchlorosilane 
and 50µl of dimethylformamide was added.   Samples were capped, vortexed and heated 
at 90°C for 20 min. then transferred to auto sampler vials for GC-MS analysis on an 
Agilent 6890 Series GC system with a 5973 Network Mass Selective Detector with an 
Aletch EC-5 30-m column (ID 0.250 µm, 0.25 µm film thickness).   The initial column 
temperature was set at 100°C with a 1 min hold followed by a single ramp of 10°C/min to 
a final temperature of 300°C.  Sample injection volumes were 1µl with the split adjusted 
as required to obtain  satisfactory peak areas.  Ions were monitored with mass-to-charge 
for Methionine 292 and 295, which elutes between 7.65 and 11.96 min.  
Thawed blood samples (100 µl) were deproteinized by the addition of 1 mL of 
10% sulphosalicyclic acid (SSA). Samples were vortexed vigorously and then placed on 
ice for 10 min in order to improve protein precipitation followed by centrifugation 
at12,000 × g  for 10 min. Supernatants were prepared on resin mini-columns as above for 
casein hydrolysates with the exception that 0.5 g of resin was prepared and  accor ingly 
elution solutions were reduced in volume by half.  Samples were lyophilized, transfer ed 
to 1 mL vials with 0.35 mL of 0.1M HCL and then dried completely under a stream of N2 
gas at 90°C  The tBDMS derivatives were prepared as for casein hydrolysates except that 
30 µL N-(t-butyldimethylsilyl)-N-methyltrifluoroacetamide with 1% tert-
butyldimethylchlorosilane and 30µl of dimethylformamide was added.  Samples were 
capped, vortexed thoroughly, and heated at 90°C for 30 min and then transferred to auto 
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sampler vials for GC-MS analysis of methionine and glycine. Column, temperature, nd 
flow settings along with the retention times and ions monitored were identical to those 
used for casein analysis. Injection volume was increased to 2 µl and the split wa  50% of 
that for casein hydrolysate analysis in order to obtain a satisfactory area. 
Dried liver and mammary tissues were pulverized to a powder in a cryogenic 
impact mill (Spex Certi Prep Freezer Mill 6850, Metuchen NJ).  Subsamples of 100g 
were homogenized with 15% ice cold sulphosalicyclic acid in 2.5 mL Eppendorf tubes. 
In order to achieve complete deproteinization of free Methionine, samples wer  further 
homogenized using a VWR AHS-200 Power Max Homogenizer (VWR International, 
West Chester, PA) with a 5 mm diameter generator.  Samples were place on ice for 15 
min following homogenization and then processed in a manner identical to the blood 
samples.  Sample pellets following deproteinization were stored at -40°C for further 
analysis. 
Liver and mammary free methionine enrichment was analyzed by GC-MS (HP 
6890; Agilent) fitted with a HP-5 column (0.250 µm ID, 0.25 µm film thickness, 51 m) 
and mass spectrometer detector (HP 5973N Mass Selective Detector, Agilent). The initial 
column temperature was set at 100°C with a one min hold followed by an initial ramp of 
40°C/min to a temperature of  220°C and a final ramp of 10°C/min with a final 
temperature of 300°C.  Sample injection volumes and split were adjusted as required to 
obtain a satisfactory peak areas. Ions with mass-to-charge were monitored for methionine 
292-295 at a retention time of 11.1 min.  
For liver tissue, following initial deproteinization, samples were re-suspended in 1 
mL ice cold methanol, vortexed for 15 s and then placed on ice for 5 min.  Samples were 
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centrifuged at 1200 × g for 10 min, the supernatant containing fat was discarded and the 
process was repeated.  Samples were dried completely in a convection oven at 50°C.  Dry 
liver samples (10 mg) were transferred to hydrolysis tubes, containing 2 mL of 2M HCL 
with 0.05% DTT. Samples were heated for 18 h at 110°C to facilitate complete 
deproteinization of the tissue.  Once cool, a 1 mL fraction of the sample was procesed in 
a manner identical to the blood samples with the exception of rinsing the resin bed with 
16 mL of dH2O following sample application to ensure the elute was at a neutral pH.    
Approximately 100 mg of the labeled methionine diet was ground by mortal and 
pestle and hydrolyzed with 4 mL of 2M HCL with 0.05% DTT for 18 h.  The sample was 
then filtered (#4 Whatman) to remove particulate matter.   Half of the filtrate w s then 
applied to a mini-column containing 2 g 50W-X8 100-200 mesh hydrogen form resin 
beds (Bio-Rad, Hercules, CA) that was prepared with 24 mL d H20. Following sample 
application, the resin bed was washed with dH20 until the elution reached a neutral pH.  
The sample was then eluted with 8 mL 2N NH4O  and 6 mL dH20 into a 40 mL plastic 
vial with a snap top closure.  The sample was lyophilized as described above.   Once dry 
the sample was taken up in 2 mL dH20, 400 µL was transferred to a 2 mL vvial and 
blown down under a stream of N2 gas at 40°C.  To the dry sample 50 µL N-(t-
butyldimethylsilyl)-N-methyltrifluoroacetamide with 1% tert-butyldimethylchlorosilane 
and 50 µLof acetonitrile was added.  The sample was heated at 90°C for 20 min and 
analyzed in the same manner as the liver free methionine. 
 
Calculations and Statistical Analysis.  Methionine isotopic enrichment was expressed as 
atoms percent excess (APE):  
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   APE = 100 x (Ri-Ro)/(1+ Ri-Ro )    
Where Ro and Ri are the ratios of m/2 295/292 for a sample at natural abundance and an 
enriched sample respectively.  This corrects the observed sample enrichmet (Ri) for the 
natural isotopic abundance based on the enrichment of control samples (Ro) and 
establishes the isotopic enrichment resulting from tracer feeding (APE) (1).  
Statistical analysis of pup growth, dam weight and milk isotopic data collected 
over time were analyzed as repeated measures using ANOVA.  Statistical analysis was 
completed using the MIXED procedure of SAS 9.3 (SAS/STAT Inst. Inc., Cary, NC) 
with the repeated option and autoregressive covariance structures.  The statistical model 
included: Block, Treatment, Day and Day by Treatment interaction with dam within 
treatment as a random effect used as the error term for testing treatment effects.  Day and 
day X treatment interactions were tested against residual error.  Data are presented as 
least squares means with pooled SEM with differences between treatment means 
considered significant when P <  0.05.    
Statistical analysis of the effect of dietary supplement on methionine isotop c 
enrichment of mouse blood, casein and tissue on d 5 postpartum were analyzed using the 
MIXED option of SAS 9.3. Isotopic enrichment and ratios were treated as a continuous 
response variable, treatment was treated as the fixed effect and block was therandom 
variable.  The statistical model included: block, treatment and block by treatment 
interaction.  Block and block by treatment interactions were tested against residual error.  
Data are presented as least squares means with pooled SEM with differences betwe n 




Dam and pup weight changes.  Dam food intake did not differ between diets (Table 2.2). 
Dam weights measured every other d were measured from d 2 to d 12 postpartum, a 
significant effect of diet (P = 0.002) was noted for the average dam weight across the 
entire period with methionine fed mice weighing slightly more than there choline 
counterparts.   Analysis of dam weights by d indicated that the effect of diet was only 
significant at d 4 (P = 0.04), but no statistical significance existed for the remaining days.  
Dam d 2 to 12 total weight gain/loss was not affected by treatment.  Additionally 
gain/loss by d from d 2 to d 12 post parturition was not significantly different between th 
treatment groups (Tables 2.3 and 2.4).     
Table 2.5 summarizes pup litter weights and average weights.  There was no 
significant effect of diet on average litter weights from d 6 to 12.  The average pup 
weight was significantly different (P  = 0.04) from d 6 to 12 with regards to treatment, 
methionine pups weighing slightly more on average from d 6 to d 12 than their choline 
counterparts.  The average pup weight was highly significant (P = 0.03) at d 6 but was 
not considered significant at d 8, 10 or 12 as reported in table 2.8 and figure 2.3.  Pup 
average daily gain is summarized in Table 2.6, there was no significant effect of 
treatment on the average of daily gain over d 6-12.  There was a trend for higher gan 
among the choline treatment (P = 0.07) for d 6-8, 8-10 and 10-12 (Figure 2.2).  Total 
weight gain from d 6 to 12 post parturition for the litter and average pup was not 
significantly different between the two diets as summarized in Table 2.6.   
Diet, Tissue, blood and milk enrichment.  
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Analysis of the methionine supplemented diet indicated methionine methyl group 
enrichment of 54.89%.  Methionine enrichments for liver, blood, and mammary tissue 
collected on d 15 postpartum are shown in Table 2.7.  As expected, methionine 
enrichment was 3 to 10 fold greater in dams fed MET vs. those fed CHOL. For dams fed 
MET, liver tissue and free methionine along with whole blood and mammary tissue 
methionine enrichments were similar.  In dams fed CHOL, methionine enrichments w re 
much greater in liver, than in blood, mammary tissue or casein.   
Dams receiving CHOL blood enrichment values of 4.08, roughly half the 
enrichment values of the liver free and liver tissue methionine (9.26 and 8.27).    In 
contrast to dams fed MET, mammary tissue and casein enrichments were lower than in 
whole blood and liver.   
Relative enrichment ratios are summarized in Table 2.7.  As expected, enrichment 
ratios between liver tissue and liver free methionine were not different in both trea ments.  
However, enrichment ratios of casein:whole blood were lower and liver tissue: free 
methionine were greater (P < 0.01) in animals fed CHOL vs. MET suggesting substantial 
differences in methyl transfer from choline in mammary vs. liver tissue.   
 
Discussion   
Production Measures. In an earlier study in  C57BL/6 mice fed a protein adequate diet 
had pups that weighed approximately .5 g more on d 10 of lactation than was observed in 
this study on d 12 of lactation (11).   This data indicates that pups in both treatment 
groups were methyl group deficient prior to d 10 of the treatment period.   MET 
treatment pups initially performed better based on calculations of growth ates at d 6 (P = 
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0.03).  By the conclusion of the study there was no significant difference in the average 
pup weights between the diets.  Cumulatively this data suggests that mice receving th  
MET supplemented diet were better able to synthesize milk than their CHOL 
supplemented counterparts during the early stages of lactation, but experienced a more 
rapid decline in production once body stores of MET became limiting.  Both treatments 
groups appear to have reached a peak rate of average daily gain on or before d 6 with a 
decline in pup average daily gain across d 6-12 in contrast to pups on protein adequate 
diets (11).   
 
Tissue, blood and milk enrichment. Both treatment diets contained casein as the protein 
component and therefore also contained MET, this may have reduced the rate at which 
body stores of protein would have been catabolized to meet lactation demands.  However, 
there were no treatment effects on liver tissue:liver free and mammary tissue:casein 
enrichment ratios suggesting that both treatments resulted in similar fractional rates of 
MET remethylation.    
Mice receiving the CHOL supplemented diet had a MET liver tissue enrichment 
of 9.26 APE, establishing a minimum choline contribution to homocysteine 
remethylation in the liver.  These results are consistent with earlier studie  that identified 
the liver as a major site of homocysteine remethylation in other mammals (4, 12, 13)
In contrast, mammary tissue does not appear to be a major site of MET 
remethylation from CHOL in the lactating mouse, as MET enrichment in CHOL fed mice 
was half that of whole blood enrichment.   This would indicate that there is an unlabeled 
source of methyl groups that contributes to remethylation in the mammary tissue at a rate 
 49 
far in excess of that from CHOL.    This data is consistent with earlier studie in lactating 
Sprague-Dawley rats which demonstrated that free CHOL taken up by the mammary 
tissue remains predominately as CHOL or CHOL metabolites (14).   
Casein MET enrichment in both treatment groups was roughly 30% greater than 
that of the mammary tissue.  This would indicate a more highly labeled source of MET 
than that found in the mammary tissue is serving as the pre-cursor pool for casein 
synthesis.  An earlier study in lactating goats (15) in which carbon labeled CHOL and 
MET were infused via a jugular catheters demonstrated that the protein and whey 
components of milk were derived largely from the free MET pool.   Our data suggest free 
MET from the diet as well as from CHOL remethylation was a major contributo  to  
casein synthesis based on casein and whole blood enrichments.   
The present study indicates whole blood MET enrichment is significantly lower 
than casein enrichment in animals receiving the MET supplemented diet.  This may be 
explained in part by the use of whole blood in lieu of plasma.  Accurately identifying 
precursor pool MET enrichment through whole blood is limited due to the unlabelled 
fraction of red blood cells that undoubtedly dilute the enriched plasma fraction.  Female 
C57BL/6 mice at sixteen weeks of age have a packed cell volume of 51.2% that is 
comprised almost entirely of red blood cells (17).   Red blood cells may obtain up to 63% 
of their amino acids primarily from tissue rather than the free plasma pool which ould 
be more highly labeled (16).  In addition relative labeling of the MET diet is roughly half 
that of CHOL due to the unlabeled fraction of MET from casein.  
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In all likelihood, the dietary MET enrichment of 54.89% for the MET treatment is 
probably a closer estimate to the plasma free MET pool than the actual value of the whole 







TABLE 2.1   Ingredient composition of experimental diets1 
 
 
Ingredient MET CHOL 
                               g/100 g diet 
Dextrose2 70.00 70.00 
Vitamin free casein2 10.00 10.00 
Solka-floc3 5.00 5.00 
Soybean oil2  9.00 9.00 
AIN 93 Mineral Mix4 4.00 4.00 
AIN 76 Vitamin Mix5 1.50 1.50 
Choline choride6 __ 0.095 
D,L Methione6 0.30 __ 
1 Treatments consisted of 300 mg/100g diet added methionine (MET) or 95 mg/100g 
added choline (CHOL)  
2Source: Dyets, Inc. 
3Source: International Fiber Corporation 
4Source: MPBio 
5Source: ICN Biomedicals, Inc. 








------- Treatment -------   
Item MET CHOL SEM1 P-value2 
Feed, g/d  6.57 6.01 0.37 0.27 
Methyl intake, mol/d      
Casein 2.84 2.62 0.16 0.33 
[methyl,2H3] Met  3.17 --- 0.19 0.97 
[methyl-2H9] Choline
3 --- 3.18 0.18 0.97 
Total methyl, mol/d  6.00 5.81 0.35 0.64 
1 Standard error of the mean. 
2 Probability that treatment means are not different, when the null hypothesis is rejected. 
3 Estimated from dietary inclusion and isotopic purity. 
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TABLE 2.3  Dam and pup weights (g) by treatment for d 2 to d12 post parturition.  
 
 ------------ Treatment -----------   
Days Postpartum MET CHOL SEM1 P-value2 
Average Dam, g     
2-12 25.50 23.18 0.51 0.002 
2 25.46 24.20 1.31 0.47 
4 27.93 23.65 1.60 0.04 
6 25.92 23.73 1.31 0.21 
8 24.82 23.20 1.13 0.31 
10 24.97 22.32 1.13 0.10 
12 23.92 22.02 1.13 0.24 
ADG, g, 2-12 -0.35 -0.27 0.11 0.63 
Pup Data     
Litter Weight, g, d 12  14.88 13.96 0.45 0.16 
Pup Weight Average, g  
d 6- d 12 
3.71 3.42 0.09 0.04 
1 Standard error of the mean. 







FIGURE 2.1  Average pup weight d 6 to d 12 in grams Error bars indicated the standard 

























 TABLE 2.4 Methionine enrichment atoms percent excess and ratios of mouse blood, 
casein and tissue on d 5 of supplementation with [methyl-2H3] Methionine
2 
or [methyl-2H3] Choline
3.   
 
 --------- Treatment --------   
Source MET CHOL SEM1 P-value2 
Whole Blood 24.37 4.08 2.07 0.0001 
Casein 32.04 2.99 0.48 0.0001 
Mammary Tissue 19.51 1.58 1.31 0.0001 
Liver Free 26.61 9.26 1.21 0.0001 
Liver Tissue 22.75 8.02 1.29 0.0001 
Liver tissue:Liver free 0.85 0.89 0.02 0.89 
Liver free:Whole blood 1.15 2.34 0.18 0.01 
Casein:Whole blood 1.37 0.72 0.11 0.01 
Mammary Tissue:Casein 0.61 0.65 0.05 0.67 
1 Pooled standard error of the mean. 
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The objectives of this study were to determine the metabolic fates of methyl groups 
derived from dietary choline and methionine (Met) and the bio-availability of rumen-
protected choline in lactating dairy cows.   Four multiparous Holstein cows in mid 
lactation were fed a nutritionally complete basal diet except for methionine that was 
limited to 1.49 % of metabolizable protein. Treatments included the basal diet or the 
basal diet plus 15g/d rumen-protected choline chloride (RPC) in single reversal design 
with 2 wk experimental periods. To measure metabolic fates of Met and choline, cows 
received a continuous jugular vein infusion of [1-13C] Met, [methyl-13C ] Met, and 
[methyl-2H9] choline for 12 h on the final day of each experimental period.  Milk was 
collected at 3 h intervals and blood samples taken over the last 6 h.   Supplementation 
with RPC did not affect total milk yield or milk fat and protein yields which aver g d 39 
kg/d, 1634 g/d and 1110 g/d respectively. Total Met flux, Met irreversible loss, and 
remethylation were not affected by treatment and averaged 15.2, 11.5, and 4.2 mmoles/h 
suggesting that 24% of Met was remethylated in the liver. Based on plasma casein 
tracer:tracee ratios for both 13C-Met and D3-Met, a minimum of 27% of casein Met 
methyl group results from de novo methyl group synthesis occurs in the mammary gland. 
Further, upwards of 40% Met present in casein is the result of transmethylation with 
choline serving as the ultimate methyl donor. Based on differences in Met methyl flux 
rates, bio-availability of RPC was estimated to be 72%. These results illus rate the central 
role of Met and choline in methyl metabolism and the importance of methyl group 
transactions in the high producing dairy cow.  
Key Words:  choline, methionine, methyl metabolism, lactating dairy cows   
 61 
INTRODUCTION 
Methionine for lactating cows along with lysine is considered to be the first or 
second limiting amino acid in most monogastric animal and ruminant diets (Schwab et 
al., 1976). In addition to its role as a building block in protein synthesis, methionine also 
serves as the precursor for S-adenosylmethionine, which is involved in more than 100 
transmethylation biosynthetic end products (Lobley et al., 1996).  After donating its 
methyl group, S-adenosylmethionine is converted to S-adenosylhomocysteine, which in 
turn can be re-methylated to re-form methionine. 
In monogastrics, the tri-methylated compound choline is derived mainly from 
dietary sources and is the primary methyl donor for re-methylation of homocysteine to 
form methionine (Benevenga, 2007). Furthermore, choline itself is considered an 
essential nutrient due to its role as a precursor of phosphatidylcholine.  
Phosphatidylcholine is an essential component of cell membranes and it is an integral
component of lipoproteins that are essential for the removal of triacylglycerol from the 
liver. A classic symptom of choline deficiency is fatty liver and it has been proposed that 
a general deficiency of methyl groups leads to fatty liver (Pinotti et al., 2000).  Models of 
experimentally induced fatty liver in dairy cows have shown that rumen-protected 
choline (RPC) is effective in preventing and alleviating fatty liver (Cooke et al. 2007).  
In ruminant animals, dietary choline is extensively degraded in the rumen.  
Therefore choline must be synthesized endogenously or provided in a rumen-protected 
form to meet the animals needs (Pinotti et al., 2000).  The de novo synthesis of choline 
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requires three moles of methyl from S-adenosylmethionine, this further limits the net 
supply of methionine for protein synthesis.  
While some studies have demonstrated a milk production response to dietary 
choline, others have not (Pinotti et al., 2000). To date, there have been only three 
experiments (Emmanuel & Kennelly, 1984; Lobley et al., 1996; Preynat et al, 2009) that 
provide quantitative information on the metabolic fates of methyl groups derived from 
choline and methionine in ruminants. The lack of quantitative knowledge of methyl 
group transactions has limited our ability to predict when, and under what conditions, 
RPC supplementation will be effective.  Because of these limitations, an experiment was 
conducted with the objectives of determining the metabolic fates of methyl groups 
derived from dietary choline and methionine and estimating the bio-availability of RPC 
in lactating dairy cows. 
MATERIALS AND METHODS 
 
Cows and Treatments  
The methods and materials used in this experiment were reviewed and approved 
by the University of Maryland Institutional Animal Care and Use Committee (Protocol 
#R-08-06).  Four multiparous Holstein cows (672 ± 32 kg) in mid-lactation were used in 
the experiment.  Cows were housed in tie stalls bedded with wood shavings and 
individually fed a total mixed ration (TMR) that was formulated to meet the nutrie t 
requirements of a 650 kg Holstein dairy cow, 40 mo age and 90 days in milk producing 
39 kg/d milk containing 3.75% fat and 3.10% protein with an estimated feed 
consumption of 23.6 kg/d (NRC, 2001).  In order to challenge the cow’s methyl group 
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needs, the basal diet Met concentration was restricted to 1.49 % MP.  Feed intake and 
feed refusals were recorded once daily and water was available ad libitum.  Ingredient 
and chemical composition of the basal diet is presented in Table 3.1 
Dietary treatments consisted of either the basal diet alone or the basal plus 15 g 
rumen-protected choline chloride (RPC) (Reashure, Balchem Corporation, New 
Hampton, and New York).  In the RPC treatment, RPC was mixed with 394g ground corn 
and top dressed on the basal TMR once daily when cows were offered fresh TMR. 
Similary, the Control group received 454 g ground corn as a daily top-dress.  Treatments 
were applied in a single reversal design with 3 week (wk) experimental periods. Cows 
were fed the basal (Control) diet during the first wk of each experimental period to allow 
for isotope washout and minimize treatment carryover followed by treatment diets during 
the last 2 wk of each period.  
 
Isotope Infusion Procedures 
Methionine and choline methyl transfer and irreversible loss were measured on d 
21 of each period using stable isotopes of Met and choline.  Infusion and blood sampling 
catheters were placed during the morning of d 20 of each period. Infusion catheters (75 
cm) were constructed from Tygon Microbore® Tubing (ID 1.02 mm, OD 1.78mm; 
(Saint-Gobain Performance Plastics, Paris, France) and sterilized with 70% ethanol. Prior 
to insertion catheters were flushed with .9% sterile saline solution containing 100 IU/mL 
heparin.  Cows were haltered and restrained in a squeeze chute during catheterinsertion. 
A 10 by 10 cm area of the jugular groove located at the midpoint between the withersand 
the point of shoulder was clipped with a surgical clipper and then washed with 70% 
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ethanol solution.  For each catheter, a sterile 7 cm 12-guage stainless steel trocar was 
inserted into the jugular vein through which the sterile catheter was inserted 20 inches.  
The catheter was flushed with copious amounts of a 0.9% sterile saline solution followed 
by 500 IU/mL heparin saline solution in order to prevent clotting in the catheter 
overnight.  The catheter was plugged with a 17-gauge blunt that was secured with a small 
strip of Elastoplast (Beirsdorf Ag, Berlin, Germany) bandage.   Immediately cranial to the 
catheter insertion site, a 2”x3” butterfly strip of Elastoplast bandage was applied with 
Kamar adhesive (Kamar, Inc., Steamboat Springs, Colorado) to secure the infusion line 
and prevent catheter movement at the site of insertion.  Finally, an elasticneck girdle was 
placed on the animals to protect the catheter insertion sites overnight and throughout the 
infusion period.  
A single infusion solution consisting of 3.4 g  [1-13C]Met, 3.4 g [methyl-13C] Met, 
and 6.4 g [methyl-2H3] choline (Cambridge Isotope Laboratories, Andover, MA), were 
dissolved in 1475 g in 0.9% sterile saline.  The rate of infusion (30 mL/h) was calculated 
to allow for a 4% Met enrichment of blood plasma Met based on estimates of Met 
turnover in the lactating dairy cow (Bequette et al., 1997; NRC, 2001).  The tracer 
solution concentrations were calculated to limit any potential excess of Met and or 
choline that might have unduly influenced methyl group metabolism during the infusion 
period.  
Cows were milked in their tie stalls at 0600 h using a portable milker after which 
isotope infusion commenced using Minipulse-3® peristaltic infusion pumps (Gilson, Inc., 
Middleton, WI) calibrated to deliver a constant rate of infusion (30 mL/h) over the next 
12 h.  Actual infusion rates were calculated using the change in weight of the infusion 
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solution as measured throughout the infusion period and the individual isotope 
concentration.  Cows were milked every 3 h throughout the infusion period, with milk 
weighed, sub sampled and stored at 4°C for analysis. Oxytocin (20 IU) was infused via 
the blood sampling catheter in instances where milk letdown did not occur after normal
milking preparation.   Milk fat, protein, and SCC were determined by infrared analysis 
(Foss Milk-O-Scan, Foss Food Technology Corp., Eden Prairie, MN) on fresh samples 
from individual milkings collected over the last 2 d prior to isotope infusion.  
Blood samples were collected via the second non-infusion catheter at 0600 h and 
hourly from 1400 to 1800 h.  Blood was collected in a syringe containing 250 IU heparin 
solution (10 IU/mL blood collected).  Following collection syringes were gntly mixed 
and placed on ice prior processing. Catheters were then flushed with 10 mL of 100 
IU/mL heparin solution in 0.9% sterile saline, the block replaced and the catheter secured 
with a small strip of Elastoplast®.  Blood samples were centrifuged in 1000 × g for 20 
min at 4°C. The plasma fraction was pipetted into six 1 mL fractions and one 5 mL 
fraction with any remaining plasma stored as one fraction.  Samples were immediately 
frozen at -20°C.  
 
Casein Isolation and Analysis 
Immediately following the completion of each milking, milk was thoroughly 
mixed and two 12 to 14 mL subsamples of milk were collected and placed on ice until 
processed within 20 min post collection.  Samples were centrifuged in at 1000 × g for 20 
min at 4°C.   
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The remaining casein, sugar and water fraction was vortexed to break up the 
casein pellet. The two subsamples were transferred to a single 50 mL polycarbonate 
centrifuge tube (3118-0050, Nalgene, Rochester NY).  A volume of distilled H20 (d 20) 
equal to that of the sample was added leaving a final volume of 30 to 40 mL to which  
1M HCL was added until  casein precipitation occurred at a pH of 4.5 to 4.7.  The casein 
samples were refrigerated overnight to aid precipitation. Following refrigeration, the 
supernatant was gently poured off and samples were re-suspended in 30ml of dH20.  
Samples were briefly vortexed, centrifuged at 1000 × g for 15 min at 4° C, the 
supernatant removed and the sample re-suspended in dH20, followed by a another  
centrifugation 1000 × g  for 15 min at 4° C and subsequent removal of supernatant.  
Finally 30 mL of dH20 was added to the samples, they were vortexed and transferred to a 
45 ml polypropylene sample vial with punctured caps (03-341-75A, Fisher Scientific) 
and stored at -20°C.  Frozen samples were lyophilized for 48 h or until reaching complete 
dryness with dried samples stored at -20°C.   
A 20 mg sample of dry casein was placed into a 15 mL hydrolysis tube to which 2 
mL of 2 M HCL containing 0.05% dithioerythritol was added. The capped sample tube 
was vortexed vigorously for several seconds and then placed on a heating block at 110°C 
for 18 h.   Samples were cooled and transferred to 2.5 mL micro-centrifuge tube; samples 
were centrifuged briefly at 1300 rpm to collect any undigested debris.   
Amino acids were separated from acids, salts and other neutral compounds  using 
a 2 g AG 50W-X8 100-200 mesh hydrogen form resin (Bio-Rad, Hercules, CA) in 12 mL 
mini-prep columns were the resin bed had been previously prepared by washing with 24 
mL dH20.  One mL supernatant was added to the column and the resin bed was 
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monitored for elution cessation, at which point, 16 mL dH20 was applied to the column.     
Column retained amino acids were eluted with 8 mL of 2M NH4O  followed by 4 mL 
dH20.  The ammonia and water elutions were collected in 45 mL polypropylene sample 
vial with punctured caps (03-341-75A, Fisher Scientific) and frozen overnight at  -20°C 
and then lyophilized until completely dry.    
Once dry, 0.5 mL of 0.1 M HCL was added, carefully pippeting around the 
bottom and lower edges of the vial to ensure that the sample was completely solubilized. 
A 100 µL subsample was transferred to a 1 mL V-Vial and dried under N2 gas.    To the 
dried sample, 50 µL of N-(t-butyldimethylsilyl)-N-methyltrifluoroacetamide 
(MTBSTFA) and 50 µL of dimethylformamide (DMF) were added.  Samples were 
capped, vortexed and heated at 90°C for 20 min.  Samples were transferred to auto 
sampler vials and analyzed by GC-MS analysis on an Agilent 6890 Series GC system 
with a 5973 Network Mass Selective Detector using a HP-5 60 meter column (ID 250.0 
µm, 0.25 µm film thickness).  The initial temperature was set at 160°C followed with a
ramp of 10°C/minute to 300°C.  Injection volumes were 1 µL, split was adjusted in order 
to obtain a satisfactory area. Ions with mass-to-charge of 246 to 249 were monitored for 
Gly at a retention time of 12.02 min while Met was monitored with mass-to-charge ratios 
of 292 to 295 and 320 to 323 at a retention time of 16.43 min. 
 
Plasma Amino Acid Analysis 
Thawed plasma samples (0.5 mL) were deproteinized with 0.5 mL of 15% 
sulphosalicyclic acid (SSA).  Following the addition of SSA, samples were vortexed 
vigorously then placed on ice for 10 min in order to improve protein precipitation.  
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Samples were centrifuged for10 min at 1300 rpm.  The supernatant was applied by 
pipette to 0.5 g AG 50W-X8 100-200 mesh Hydrogen form resin (Bio-Rad, Hercules, 
CA) in 12 mL mini-prep columns previously by washing with 6 mL dH20.  Following 
initial elution, an additional wash of 8 mL dH20 was applied.  Amino acids were eluted 
with 2 mL of 2M NH4OH followed by 1 mL dH20 and collected in 4 mL Wheaton vials.  
Vials were capped with punctured tops and frozen overnight at -20°C and then 
lyophilized until completely dry.    
Dried samples were transferred to 1 mL V-Vials with 0.35 mL of 0.1M HCL and 
then dried under N2 gas.  To each sample 30 µL MTBSTFA with 1% tert-
Butyldimethylchlorosilane and 30 µL acetonitrile was added.  Samples were capp d, 
vortexed thoroughly and heated at 90°C for 20 minutes.  Once cooled, samples were 
transferred to auto sampler vials for analysis via GCMS analysis was conducted on an 
Agilent 6890 Series GC system with a 5973 Network Mass Selective Detector using ah a 
HP-5 51 m column (ID 250 mm, 0.25 µm film thickness).   The initial temperature was 
set at 100°C with a one minute hold followed by two ramps one of 40°C/minute to 220°C 
and a final ramp of 10°C/minute to 300°C.  Injection volumes were 1 µL, split was 
adjusted in order to obtain a satisfactory area. Glycine and Met ions monitored were as 
for casein but at retention times of 7.09 and 11.09 min, respectively.  
 Plasma samples for amino acid (AA) analysis followed the same protocol as that 
for Met and Gly with the exception of the addition 0.125 g of an amino acid standard 
containing 3 mg [U-13C]  algae (Table 3.2), 13 nmole S-methyl-D3-methionine, 100 
nmole L-glutamine-amide-15N,  10 nmole L-tryptophan-[indole- D5]
 were added to 0.5 g 
plasma prior to analysis by GCMS.  Analysis was conducted on an Agilent 6890 Series 
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GC system with a 5973 Network Mass Selective Detector with a HP-50+ 30 m colu n 
(ID 250 µm, 0.25 µm film thickness.  The initial column temperature was set at 100°C 
with a one min hold followed by two ramps one of 10°C/min to 280°C and a final ramp 
of 50°C/min to 300°C.  Injection volumes were 0.1 µL, split was adjusted in order to 
obtain a satisfactory area. Ions monitored are summarized in Table 3.3. 
Plasma urea preparation was identical to the plasma amino acid with the 
exception of 3.7 nmole of labeled urea [15N2] standard utilized in lieu of the amino 
acid/algae tracer.  Following elution 30 µL of the sample was transferred to a 1 mL V-
Vial and dried under N2 gas.  Samples were derivatized in 50 µL of DMF and 50 µL of 
MTBSTFA with 1% BDMCS at 110° for 30 min. Samples were analyzed by GCMS as 
per AA except the initial temperature was set at 160°C followed by two ramps: one of 
10°C/min to 230°C and a final ramp of 50°C/min to 300°C.  Injection volumes were 1 
µL, split was adjusted in order to obtain a satisfactory area. Urea ions were monitored as 
a mass:charge ratios of 231 and 233 at a column retention time of  4.38 min and dwell 
time of 50. 
Isotopic purity of infusion isotopes [1-13C] Methionine and [13CH3] Methionine 
were completed in a manner identical to that for plasma analysis with the following 
exceptions.  Five mg of the labeled isotopes were taken up in 1 mL of 0.1N HCL and 
vortexed thoroughly.  Ten µL of each solution were dried under N2 gas and samples were 
derivatized with 50 µL of MTBSTFA with 1% BDMCS and 50 µL acetonitrile.  The 
isotopic purity of the [1-13C]Met tracer was calculated to be 99.78 APE (M+1)   and 
[13CH3] Met tracer isotopic purity was 98.85 APE (M+1) based on GCMS analysis. 
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Methionine standard solutions of unlabeled Met, [1-13C] Met, [13CH3] Met, and  
[D3 Methyl] Met were used to create four standard curves. One standard curve was of 
unlabeled Met, and three standard curves were a solution of unlabeled Met and one of the 
labeled Met standards.  The curves were calculated to have an APE of 1 to 5.  The 
standards were processed and analyzed in the same manner as for plasma Met samples.  
Plasma samples for urea concentration analysis were processed in the same manner as 
plasma Met.  Plasma urea concentrations were corrected using a standard curve of
unlabelled urea and [15N2] urea.  The standards were processed and analyzed in the same 
manner as the plasma urea samples.  
 
Calculations 
 Data from standard curves for Met were used in calculations of the tracer:tr e 
(TTR) ratios.  Tracer:tracee ratio is defined as the moles of tracer (labeled ion) per 100 
mol of the tracee (unlabeled ion) and calculated as:   
TTR= ((EX  / EY) - intercept) / slope       (1) 
The above equation corrects the tracer (EX ):tracee (EY) ratio using the slope and 
intercept derived from the respective standard curve.   
As 1-13C-Met, in contrast to 13CH3-Met, does not lose its labeled atom during 
transmethylation, 1-13C-Met flux can be used to calculate total Met carboxyl flux using 
the equation:  
Met carboxyl flux = (Ei / EMi) × R      (2)  
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This equation calculates Met carboxyl flux using M+1 TTR 1-13C Met (EMi)  and 
corrects for isotopic purity of the tracer (Ei), tracer infusion rate (R, mmol/hr) and 
expresses the total Met flux in the context of 1 h.  
Total Met methyl flux was calculated as:  
Met methyl flux = (Ei / EMi) × R      (3) 
This equation calculates Met methyl flux using M+1 TTR 13CH3-Met and corrects for 
isotopic purity of the tracer (Ei), infusion rate R and expresses methyl flux in the context 
of 1 h. 
Methionine remethylation (mmol/h) was calculated based on the difference 
between the 1-13C-Met flux and the 13CH3-Met methyl flux:  
 
Met remethylation = Met methyl flux - Met carboxyl flux   (4)  
 
 
Where Met methyl flux and Met carboxyl flux are expressed as mmol/hr. 
 
 Fractional remethylation is ratio of the rates of Met remethylation and 13CH3 Met 
methyl flux:   
Fractional remethylation = Met remethylation / Met methyl flux (5) 
Relative transmethylation activity can be established using plasma concentrations 
of 1-13C-Met and 13CH3-Met given that the concentrations in the infusion solution and the 
infusion rate are known.  In this study, relative transmethylation is defined as the ratio of 
plasma 13CH3-Met:1-
13C Met.   A relative transmethylation ratio of 0.9 would indicate 
that roughly 10% of Met is undergoing transmethylation whereas a ratio of 0.1 would
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indicate that 90% of Met is undergoing transmethylation.   Relative transmethylation 
activity (RTMR) was estimated as: 
 
RTMR = [M+1 TTR 13CH3-Met] / [M+1 TTR 1-
13C-Met]  (6) 
 
Where [M+1 TTR 1-13C Met] was calculated as the difference between the 321:320 TTR 




Daily feed intake and milk production were averaged over the 7 d of each experimental 
period.  Milk composition data, were averaged by cow over the last 2 d of each 
experimental period.  Milk yield and composition were used to calculate fat, protein and 
lactose yields.  Fat-corrected milk (3.5%) was estimated using the equation of Tyrell and 
Reid (1965).  All production data was analyzed using the GLM procedure of SAS 9.22 
(SAS/STAT Inst. Inc., 293 Cary, NC).  The model included fixed effects of treatment, 
cow and period. Statistical analysis of plasma amino acids and urea concentration, casein 
isotopic enrichments and flux rates were analyzed as repeated measures ANOVA using 
the MIXED procedure of SAS 9.2 (SAS/STAT Inst. Inc., 293 Cary, NC) with the 
repeated option and autoregressive covariance structures.  The statistical model included 
the fixed effects of treatment, cow, and period. Finally, differences between m ans of 
enrichment ratios within treatment were analyzed using the TTEST procedure of SAS 
9.2. All data are presented as least squares means with a pooled SEM where differences 




Feed intake was not affected by treatment and averaged 24.0 kg/d across 
treatments (Table 3.4). While numerically greater for RPC there was no treatment effect 
on milk, milk fat, or milk protein yields which averaged 39 kg/d, 1634 g/d and 1110 g/d, 
respectively (Table 3.4) across treatments.  
Plasma amino acid and urea concentrations are summarized in Table 3.5.   There 
was no indication of a treatment effect on plasma amino acid concentrations. However, 
there was a trend (P < 0.09) for higher urea concentrations with the RPC treatment.  
Isotopic enrichment plateaus were achieved during the 12 h infusion. As example, 
Figure 3.1 shows the tracer:tracee ratio plasma and casein D3-Methyl methionine during 
by infusion [methyl-2H3] choline infusion. Somewhat surprisingly, casein Met-Methyl 
enrichment plateaued earlier and was less variable (SEM = 0. 01) than plasma 
enrichment.  However, differences due to time of sampling were not significant and me  
concentrations for all sampling periods were used in the flux measurements.   
Whole body Met flux and transmethylation relative activity as measured in 
plasma and casein are in Table 3.6. Rumen-protected choline had no effect on methionine 
methyl or carboxyl flux, or fractional remethylation although in each instance, they were 
numerically lower than the Control. Methionine carboxyl flux averaged 11.45 mmole/h 
which would correspond to a daily equivalent of 41 g/d.  Due to Met remethylation, 
methyl flux was greater than carboxyl flux.  Fractional Met remethylation averaged 0.242 
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across treatments suggesting that at a minimum, 24% of Met is re-methylated using the 
difference between Met methyl and Met carboxyl flux rates.   
Transmethylation as measured in plasma was not affected by treatment.  There 
was a tendency for greater transmethylation (P= 0.09) in the Control vs. RPC as 
measured in casein (Table 3.6).  However the ratio of plasma:casein relative 
transmethylation was not different between RPC and Control.  For all tracers measured, 
there was no difference in plasma or casein enrichment between Control and RPC.   
Treatment had no effect on plasma:casein enrichment as measured by 13CH3 Met 
and 1-13C-Met.  Moreover, the ratio of 13CH3-Met plasma:
13CH3-Met casein and  1-
13C-
Met plasma:1-13C-Met casein were not significantly different within the Control or RPC 
treatments. However, within treatment ratio of (13CH3-Met plasma:
13CH3-Met casein): 
(D3-Met plasma: D3-Met casein) enrichment was significantly different (-2.78, P = 0.04) 
for Control and tended be different (-2.74, P = 0.06) for the RPC treatment. 
 
DISCUSSION 
While supplementation with RPC did not elicit a significant production response, 
this experiment had insufficient numbers of cows to measure production responses. 
Rather our objectives were designed to identify the effect of RPC on several biological 
measures.   
Plasma free amino acids concentrations were not affected by RPC. Most notably, 
Met concentrations as measured in plasma were not significantly different between the 
treatment and control.  If RPC supplementation was sparing Met then we would have 
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anticipated an increase in free Met and subsequently a decrease in plasma glycine 
concentrations but this did not occur (Selhub, 1999).    
Previously, Lobley et al. (1996) demonstrated a reduced need for homocysteine 
remethylation in sheep fed a Met limiting diet with supplemental choline infusion.  The 
results of that study suggested that choline may be sparing Met through reduced de novo 
choline synthesis, rather than increased the rate of homocysteine remethylation (Lobley et 
al.,1996).  More recently, Preynat et al.,(2009) demonstrated an increased rate of Met 
remethylation in Met supplemented diets; counter to the theory that adequate diet ry
methionine would reduce the need for remethylation of homocysteine.   In the current 
study there was no effect of RPC supplementation on the rate of homocysteine 
remethylation.  However, our average remethylation rates (4.2 mmol/h) across 
treatments, were much greater than reported by Preynat et al. (2009), (2.6 mmol/h).  
Conversely, average Met methyl flux was lower (14.1 mmoles/h) in this experiment than 
reported by Preynat et al. (2009) (22.2 mmoles/h). Perhaps, the greater rates ofMet 
remethylation in the present study were reflected in reduced rate of total Met flux when 
compared to those reported by Preynat et al. (2009).     
This experiment did not show a difference between RPC and Controls in 
fractional rates remethylation (Table 3.6).  However, relative transmethylation rate as 
measured in casein TTR tended to be higher in the Control than in the RPC treatment 
(P=0.09).   The ratio of 13CH3-Met plasma:
13CH3-Met casein and  1-
13C-Met plasma:1-
13C-Met casein were not different between Control and RPC  indicating that Met methyl 
loss was minimal within the mammary tissue.   
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In both the Control and RPC groups comparison of D3-Methyl Met enrichment in 
plasma and casein with that of 1-C13-Met enrichment in plasma and casein suggested that 
upwards of 40% Met present in casein had undergone transmethylation with choline 
serving as the ultimate methyl donor.    Furthermore this data suggests that choline is 
serving as a major contributor of methyl groups for methionine remethylation within the 
mammary tissue. 
In an earlier study in lactating goats (Emmanuel and Kennelly, 1984) where 
uniformly labeled 14C choline was infused for 5 h, 14C was not recovered in either plasma 
or casein Met. This contrasts with this study where choline methyl was recover d in both 
fractions.   
Conceivably, the longer infusion period in this study (12 h) may have allowed for 
choline-methionine transmethylation to occur in the liver providing a plasma free pool of 
labeled methionine from which casein could be synthesized.  Additionally, the longer 
infusion period appears to have allowed for [methyl-2H3] choline to be taken up by the 
mammary tissue and subsequently act as a methyl donor for casein Met synthesi .  T is 
study is the first to demonstrate the mammary utilization of choline methyl for 
homocysteine remethylation.  
Finally, choline biovailability can be indirectly estimated from methyl flux rates 
between treatments. The RPC treatment provided and additional 0.107 moles (15g) of 
choline chloride compared with the control diet.  Conceivably this would make an 
additional 4.47 mmoles/h of choline methyl available for Met synthesis assuming one 
methyl group per mole choline (Selhub,1991). Based on the difference in Met methyl 
flux between the RPC and Control (3.25mmoles/h), this would suggest that the 
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bioavailability of RPC is approximately 72% if the difference noted between the control 
and treatment groups are due to solely to a treatment effect.   
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 Table 3.1  Ingredient and chemical composition of basal diet (DM basis) 
Ingredients % of DM 
Corn silage 47.88 
Alfalfa hay 7.42 
Corn grain, ground 11.75 
Citrus pulp 3.71 
Soybean meal 14.85 
Wet brewers grains 7.79 
Calcium Carbonate 0.65 
Salt 0.34 
Magnesium oxide 0.15 
Sodium bicarbonate 0.51 
Potassium magnesium sulfate 0.10 
Calcium phosphate monobasic 0.38 
Trace minerals and vitamins1 0.10 
Chemical composition (% of DM)  
DM  53.89 




Lysine, % of MP 5.49 




Ca  0.84 






1Trace mineral and vitamin mix provided (per kg DM) 15 mg Mn, 50 mg Zn, 
10 mg Cu, 0.60 mg I,  0.20 mg Co,  0.30 mg Se,  3,000 IU Vitamin A, 1600 IU  
IU Vitamin D3, and 50 IU Vitamin E. 
2Estimated from NRC (2001).    
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Table 3.2 Amino acid composition of [U-13C] algae 
    
Amino Acid µM/g Algae Solution 
Alanine 0.297 
Arginine 0.129 
Aspartic Acid 0.247 






Methionine, D3 0.037 
Phenyalanine 0.101 
Proline 0.174 














 Time, min 
Dwell  
Time1 
Ala 262, 263 7.02 100 
Gly 246, 248 7.51 100 
Val 288, 293 8.25 100 
Leu 302, 308 8.59 100 
Ile 302, 308 9.02 100 
Pro 286, 291 10.00 100 
Ser 390, 393 11.46 100 
Thr 404, 408 11.67 100 
Met, D3 320, 322 12.24 100 




Orn 286, 291 14.10 100 
Glu 432, 437 14.47 100 




Gln-1 431, 436 16.17 100 
Arg 442, 448 16.44 100 
Tyr 302, 304 17.62 100 
His 440, 446 18.03 100 






Table 3.4 Effect of rumen-protected choline (RPC)1 supplementation on dry matter 
intake (DMI) and milk production 
 ------ Treatment -------   
Item Control RPC SEM2 P-value3 
DMI, kg/d 23.3 24.8 1.14 0.42 
Milk, kg/d  37.3 40.8 2.10 0.36 
  Fat, %   4.19 4.15 0.26 0.64 
  Protein, % 2.90 2.82 0.06 0.39 
3.5% FCM3 41.8 44.8 3.8 0.60 
Fat, g/d 1587 1680 181 0.75 
Protein, g/d 1079 1142 36 0.34 
SCC4 689 19 472 0.42 
1 Cows were supplemented with 15 g/d rumen-protected choline chloride.  
2 Standard error of the mean. 
3 Probability that treatment means are not different, when the null hypothesis is rejected. 
4 Somatic Cell Count; One cow during the control period had SCC about 2 million but did 
not show signs of clinical mastitis or illness causing and elevated mean SCC for the 
Control treatment. 
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Table 3.5 Effect of rumen-protected choline (RPC)1 supplementation on plasma   
essential and nonessential amino acid (AA) and urea concentrations. 
 
 ---- Treatment ----   
Item Control RPC SEM2 P-value3 
Essential AA (µM/L)     
Ile 124.0 123.8 14.7 0.98 
Leu 185.6 182.6 21.6 0.86 
Lys 59.8 59.1 6.4 0.93 
Met 39.0 37.3 1.5 0.31 
Phe 55.0 61.4 3.8 0.21 
Thr 66.1 63.1 7.4 0.79 
Val 301.5 303.4 42.7 0.94 
Nonessential AA (µM/L)     
Ala 179.4 191.0 18.0 0.34 
Asp 6.7 6.6 0.4 0.90 
Gln 167.6 157.9 17.7 0.64 
Glu 26.5 26.5 3.4 0.99 
Gly 174.0 140.3 14.9 0.16 
Ser  70.9 61.6 6.2 0.33 
Urea (mmol/L) 6.2 7.6 0.3 0.09 
1 Cows were supplemented with 15 g/d rumen-protected choline chloride.  
2 Standard error of the mean. 





Table 3.6 Effect of rumen protected choline (RPC)1 supplementation on methionine flux, 
re-methylation, whole body and mammary transmethylation relative activity, 1-13C, 
13CH3, and D3, methionine tracer:tracee ratio
1. 
 
 ---- Treatment----   
Item Control RPC  SEM2 P-value3 
Methionine Methyl Flux (mmol/hr)4 16.81 13.56 5.60 0.69 
Methionine Carboxyl Flux (mmol/hr)5 12.56 10.34 3.97 0.71 
Re-methylation (mmol/hr)6 4.57 3.82 2.04 0.80 
Fractional Re-methylation7  0.258 0.227 0.03 0.52 
Transmethylation relative activity    
   Plasma8 0.751 0.790 0.03 0.39 
   Casein8 0.850 0.877 0.009 0.09 
   Plasma:Casein Ratio  0.901 0.884 0.03 0.73 
Methionine TTR (mole:100 mole)    
   Plasma D3–Met 6.27 6.13 0.46 0.85 
   Casein D3–Met 4.93 4.92 0.02 0.44 
   Plasma:Casein D3–Met 1.27 1.25 0.08 0.92 
   Plasma 1-13C-Met 5.47 6.36 0.95 0.58 
   Casein 1-13C-Met 1.55 1.55 0.98 0.97 
   Plasma:Casein 1-13C-Met 3.55 4.15 0.62 0.56 
   Plasma 13CH3–Met 5.10 5.57 2.13 0.47 
   Casein 13CH3–Met 1.22 1.35 0.10 0.86 
   Plasma:Casein 13CH3–Met 4.05 4.00 1.39 0.98 
Plasma:Casein 13CH3–Met : 
Plasma:Casein 1-13C-Met 
-.50 ---- 0.65 0.21 
---- 0.14 2.02 0.89 
   Plasma:Casein 13CH3–Met : 
Plasma:Casein D3–Met 
-2.78 ---- 1.71 0.04 
---- -2.74 1.91 0.06 
1 Cows were supplemented with 15 g/d rumen-protected holine chloride.  
2 Standard error of the mean. 
3 Probability that treatment means are not different, when the null hypothesis is rejected. 
4 Met Carboxyl Flux = (Ei / EMi)*R  (M+1 TTR 1-
13C Methionine (EMi), isotope purity of tracer (Ei), tracer 
infusion rate (R). 
5 Met Carboxyl Flux = (Ei / EMi)*R  M+1 TTR 1-
13C Methionine (EMi)  and isotope purity of tracer (Ei), 
tracer infusion rate (R).  
6 Re-methylation  = Met Methyl Flux - Met Carboxyl Flux 
7 Fractional Re-methylation =  Met Re-methylation / Met Methyl Flux 
8 RTMR = [M+1 TTR 13CH3-Met / [M+1 TTR 1-
13C -Methionine]  [M+1 TTR 1-13C-Met] was calculated 





Figure 3.1 Mean plasma () and milk casein () [D3-Methyl] methionine enrichments 
across treatment and sampling time as measured by tracer:tracee ratio during 
isotope infusion on d 14 of each experimental period. Choline [D3-Methyl] 
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